Blog - Page 3171 of 5754

WednesdayJan 02, 2013 7:40 am

Petaquilla Minerals Ltd. (PTQMF) Receives and Accepts $140 Million Loan Facility

Petaquilla Minerals has received and accepted from Red Kite Mine Finance Trust I (the lender) an indicative term sheet for a loan facility, in which the lender has offered to provide Petaquilla with a loan facility for an aggregate $140 million to develop, construct, and meet working capital requirements for its projects in Panama and Iberia. Closing of the loan facility is expected to take place on or near Jan. 15 and is subject to customary due diligence, regulatory approvals, and final legal documentation that reflects the terms of the term sheet. Upon closing, an initial tranche of $90 million…

MondayDec 31, 2012 2:17 pm

Bergamo Acquisition Corp. (BGMO) Offers an Alternative to Developing Nations

It’s a sad fact that hundreds of millions of people around the world do not have regular access to the fundamental requirements of a healthy life, such as clean water or basic electrical power. Every year millions of people, many of them children, perish as the result of water related diseases, almost all of them in developing nations. To make matters worse, millions of people are added to cities in these countries every year, cities that do not even have the utilities to support their existing inhabitants. World population is projected to top 8 billion over the next 20 years,…

MondayDec 31, 2012 2:17 pm

Cardium Therapeutics, Inc. (CXM) Promotes Wellness and Prevention

When Cardium Therapeutics recently acquired To Go Brands, a San Diego based nutraceuticals developer, it was a major expansion of Cardium’s original Medpodium nutraceutical line, and reflective of the company’s support for the nutraceutical side of their business. Cardium, known for its developments in the area of regenerative medicine, is also becoming a growing player in the area of wellness and disease prevention. To Go Brand products cover a range of weight-loss and energy markets for active professionals, but also include the following offerings designed to promote basic nutritional health: Healthy Belly is a probiotic digestive mix of live “friendly”…

MondayDec 31, 2012 10:47 am

The Guitammer Company, Inc. (GTMM) Management Links Arms with Shareholders

One of the things investors look for in a company is the quality of the management team and the alignment of the team’s personal interests with those of the company’s shareholders. Do key executives have a direct personal interest in the company, or is their involvement strictly professional? The Guitammer Company answered that question with their recent Form 4 filings with the SEC. CEO Mark Luden received no increase in pay this past year (or in prior years), but was instead compensated with options for 3 million shares at an exercise price of $0.25 per share. It was compensation based…

MondayDec 31, 2012 7:20 am

International Stem Cell Corp. (ISCO) Breakthrough in Human Clinical-Grade Stem Cells Safely Halts Rejection

International Stem Cell Corp. reported some ground-breaking news recently, showcasing the progress the company has made towards clinical-grade, applied stem cell therapy, with the announcement that the R&D team has successfully created the first human, clinical-grade stem cell lines able to immune-match millions of people and thus sharply reduce rejection by the individual’s immune system. This revolutionary breakthrough is an extension of ISCO’s established research-grade parthenogenetic stem cell (hpSC) technology, proprietarily engineered and designed from the ground up to align perfectly with FDA regulations, as well as the Good Tissue Practice (GTP) and Good Manufacturing Practice (GMP) standards they helped…

FridayDec 28, 2012 3:03 pm

New Western Energy Corp. (NWTR) is “One to Watch”

New Western Energy continues piecing together an extremely solid portfolio of working interests across the rich hydrocarbon targets of the Gulf States region, with noted small-cap research firm, Zacks Equity Research, even bumping the price target ten cents recently (Dec 21) to $1.40 on the company’s strong market cap to reserves ratio among others things, especially in light of the new Fields Lease acquisition in Kansas (Dec 20). The 300-acre Fields Lease (100% WI) has expanded an already firm, contiguous foundation in the Chautauqua Arch area held by the company via their 1.7k-acre B&W Ranch (90% WI, acquired in March…

FridayDec 28, 2012 7:25 am

Viscount Systems, Inc. (VSYS) Receives Research Coverage from SoundView Technology Group

Earlier this morning, Viscount Systems, a developer and manufacturer of IT-based solutions for physical security systems, announced that SoundView Technology Group has published a detailed report on the company. Those who wish to receive a copy of the report should email Scott Greiper at sgreiper@securesg.com. SoundView Technology Group is known for their independent research on emerging technology companies. The research firm combines major thematic forces where technology is involved and analysis to identify the most promising companies and investment opportunities. SoundView distributes its research to institutions, investors, company managers, and individuals via proprietary platforms, the internet, and social networks. Viscount…

FridayDec 28, 2012 7:21 am

PositiveID Corp. (PSID) Signs Licensing Deal with The Boeing Company

PositiveID, a developer of airborne bio-threat detection systems for the U.S. homeland defense industry and creator of advanced technologies for rapid medical testing and diabetes management, last week entered into a license and teaming agreement with The Boeing Company. Per the agreement, which includes a license fee to PositiveID of $2.5 million, Boeing has the exclusive license to manufacture and sell PositiveID’s M-BAND (Microfluidics-based Bioagent Networked Detector) airborne bio-threat detector for the U.S. Department of Homeland Security’s (DHS) BioWatch Generation 3 opportunity, as well as other opportunities that may arise in the North American market. PositiveID will retain exclusive rights…

ThursdayDec 27, 2012 2:14 pm

Umbrella Research Initiates Coverage on TNI BioTech, Inc. (TNIB) and Sets $26 Price Target

Earlier today, TNI BioTech, a biotech company focused on utilizing patented immunotherapy to activate and mobilize the body’s immune system to combat fatal diseases, announced that Umbrella Research is now covering the company with a “buy” rating and $26 price target. The entire 33-page report has been posted on the company’s Web site at http://www.tnibiotech.com/investor-relations/reports The following is an excerpt of the report: “It is our opinion that TNI presents investors with significant upside from current prices based on a two-fold growth strategy including: the near term commercialization of its existing immunotherapies targeting cancer and HIV/AIDS; coupled with the potential…

ThursdayDec 27, 2012 7:24 am

Stellar Biotechnologies, Inc. (SBOTF) KLH Technology Primed to Capture Vast Therapeutic Vaccine and Immune Testing Territory

Stellar has rapidly secured access to a key area of the burgeoning biomedical space through the development and patenting of a renewable method for extraction of KLH, or Keyhole Limpet Hemocyanin (complex oxygen-carrying metalloprotein), a vitally important and highly potent protein. KLH is derived only from the giant keyhole limpet, a kind of sea snail that lives only in the coastal waters off California. Stellar KLH™ Protein is a lucrative product with enormous potential and noteworthy market dynamics. Stellar has the sole, crucial patent for extraction of this renewable resource and recently (Dec 4) moved to further reinforce their strong…

Site Search

Company Search